Breadcrumb Home Studies Studies Search Filter Research Area AllComplications & ComorbiditiesCureTreatmentTuberculosis Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentParticipants Off Study and Primary Analysis CompletedPending Sort Study Number AscStudy Number Desc Submit Search Showing 14 studies. P1090: Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Etravirine DAIDS Number 10850 Research Area Treatment Study Status Concluded P1086: Phase II Study in HIV Positive Pregnant Women to Assess the Safety and Immunogen DAIDS Number 10835 Research Area Other Study Status Concluded P1083: Kaletra/Aluvia PK study DAIDS Number 10787 Research Area Treatment Study Status Concluded 1077HS: HAART Standard Version of the PROMISE Study (Maternal & Infant Survival) DAIDS Number 10779 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed Pagination Previous page Prev Page 1 Current page 2
P1090: Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Etravirine DAIDS Number 10850 Research Area Treatment Study Status Concluded
P1086: Phase II Study in HIV Positive Pregnant Women to Assess the Safety and Immunogen DAIDS Number 10835 Research Area Other Study Status Concluded
1077HS: HAART Standard Version of the PROMISE Study (Maternal & Infant Survival) DAIDS Number 10779 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed
